呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格

2016-11-16 美国食品和药品监督管理局 FDA

COPD生物标志物放射损伤生物标志物

FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格

中文标题：

FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格

发布机构：

美国食品和药品监督管理局

发布日期：

2016-11-16

简要介绍：

FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=343241c002009585, title=FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格, enTitle=, guiderFrom=FDA, authorId=0, author=, summary=FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格, cover=, journalId=0, articlesId=null, associationId=486, associationName=美国食品和药品监督管理局, associationIntro=美国食品和药品监督管理局是美国公共卫生及服务部的一个代理商，其由委员会办公室和4个监督核心功能理事机构组成。, copyright=0, guiderPublishedTime=Wed Nov 16 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<p>FDA生物标志物血浆纤维蛋白原在研究慢性阻塞性肺疾病患者病情加重和/或全因死亡率研究中的资格</p>, tagList=[TagDto(tagId=295, tagName=COPD), TagDto(tagId=1662, tagName=生物标志物), TagDto(tagId=65983, tagName=放射损伤生物标志物)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3851, appHits=152, showAppHits=0, pcHits=445, showPcHits=3699, likes=3, shares=26, comments=15, approvalStatus=1, publishedTime=Mon Nov 16 10:13:29 CST 2020, publishedTimeString=2016-11-16, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Mon Nov 16 10:13:24 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 11:01:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200432, encodeId=e54b12004323d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:22:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946287, encodeId=46f994628e13, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Mon Mar 08 02:31:05 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913016, encodeId=063891301647, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/ae01f47209fb4ad39e5b6d5b1aa467c8/9472d21b29ad486b8b75f47b2c63c32c.jpg, createdBy=b8e03053313, createdName=sunyuexi.love, createdTime=Sat Jan 02 08:17:28 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899944, encodeId=2e51899944ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82a05148997, createdName=14691211m03(暂无昵称), createdTime=Tue Nov 17 18:09:19 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899882, encodeId=4c928998822d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Tue Nov 17 15:37:13 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2022-03-08 genglihui01

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200432, encodeId=e54b12004323d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:22:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946287, encodeId=46f994628e13, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Mon Mar 08 02:31:05 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913016, encodeId=063891301647, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/ae01f47209fb4ad39e5b6d5b1aa467c8/9472d21b29ad486b8b75f47b2c63c32c.jpg, createdBy=b8e03053313, createdName=sunyuexi.love, createdTime=Sat Jan 02 08:17:28 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899944, encodeId=2e51899944ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82a05148997, createdName=14691211m03(暂无昵称), createdTime=Tue Nov 17 18:09:19 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899882, encodeId=4c928998822d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Tue Nov 17 15:37:13 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2021-03-08 街角对面的大米店

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200432, encodeId=e54b12004323d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:22:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946287, encodeId=46f994628e13, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Mon Mar 08 02:31:05 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913016, encodeId=063891301647, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/ae01f47209fb4ad39e5b6d5b1aa467c8/9472d21b29ad486b8b75f47b2c63c32c.jpg, createdBy=b8e03053313, createdName=sunyuexi.love, createdTime=Sat Jan 02 08:17:28 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899944, encodeId=2e51899944ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82a05148997, createdName=14691211m03(暂无昵称), createdTime=Tue Nov 17 18:09:19 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899882, encodeId=4c928998822d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Tue Nov 17 15:37:13 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2021-01-02 sunyuexi.love

    非常好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200432, encodeId=e54b12004323d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:22:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946287, encodeId=46f994628e13, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Mon Mar 08 02:31:05 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913016, encodeId=063891301647, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/ae01f47209fb4ad39e5b6d5b1aa467c8/9472d21b29ad486b8b75f47b2c63c32c.jpg, createdBy=b8e03053313, createdName=sunyuexi.love, createdTime=Sat Jan 02 08:17:28 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899944, encodeId=2e51899944ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82a05148997, createdName=14691211m03(暂无昵称), createdTime=Tue Nov 17 18:09:19 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899882, encodeId=4c928998822d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Tue Nov 17 15:37:13 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-17 14691211m03(暂无昵称)

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200432, encodeId=e54b12004323d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:22:26 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946287, encodeId=46f994628e13, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoeEYicaoSDvLzl6Rtwiblf207icXFJnruGZBAHpLm6KiaqRbm38nWkZNpaLPGsVhRnR5WjJUOnqBCSyg/132, createdBy=b1702138478, createdName=街角对面的大米店, createdTime=Mon Mar 08 02:31:05 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913016, encodeId=063891301647, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/ae01f47209fb4ad39e5b6d5b1aa467c8/9472d21b29ad486b8b75f47b2c63c32c.jpg, createdBy=b8e03053313, createdName=sunyuexi.love, createdTime=Sat Jan 02 08:17:28 CST 2021, time=2021-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899944, encodeId=2e51899944ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82a05148997, createdName=14691211m03(暂无昵称), createdTime=Tue Nov 17 18:09:19 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=899882, encodeId=4c928998822d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Tue Nov 17 15:37:13 CST 2020, time=2020-11-17, status=1, ipAttribution=)]
    2020-11-17 1361fc5d0em

    学习

    0

相关指南

慢性阻塞性肺疾病的药理管理临床实践指南

暂未更新 · 2020-09-01

COPD患者中使用单吸入器固定剂量三联疗法的Delphi共识性文件

暂未更新 · 2020-09-01

2020 ATS临床实践指南：COPD的药物治疗

美国胸科学会(ATS,American Thoracic Society) · 2020-04-13

2018 丹麦呼吸学会意见书：慢性进行性非恶性肺病患者的姑息治疗

丹麦呼吸学会(Danish respiratory society) · 2018-10-16

2018年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读

暂未更新 · 2017-12-26

2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2017-11-01